Back
Purpose Global Flexible Crdt ETF NCH CAD Vs. Aligos Therapeutics Industry Stock Comparison
Buy
66
FLX.B.TO
Purpose Global Flexible Crdt ETF NCH CAD
Last Price:
$8.61
Seasonality Move:
0.19%
Sell
30
ALGS
Aligos Therapeutics
Last Price:
$7.46
Seasonality Move:
-25.15%
Buy
66
Purpose Global Flexible Crdt ETF NCH CAD (FLX.B.TO)
is a Buy
Is Purpose Global Flexible Crdt ETF NCH CAD a Buy, Sell or Hold?
-
The current Purpose Global Flexible Crdt ETF NCH CAD [FLX.B.TO] share price is $8.62. The Score for FLX.B.TO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
FLX.B.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $7.93. The Score for ALGS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FLX.B.TO Stock Price Chart
What is Purpose Global Flexible Crdt ETF NCH CAD's stock price today?
-
The Purpose Global Flexible Crdt ETF NCH CAD share price today is $8.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FLX.B.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $7.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing slight selling pressure.
FLX.B.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.22 | Buy |
Relative Strength Index (14 RSI): | 65.11 | Buy |
Chaikin Money Flow: | 489 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.44 - 8.54) | Buy |
Bollinger Bands (100): | (8.34 - 8.7) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 46.43 | Sell |
Chaikin Money Flow: | -22445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.6 - 8.98) | Sell |
Bollinger Bands (100): | (5.21 - 9.41) | Buy |
FLX.B.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.53 | Buy |
20-day SMA: | 8.5 | Buy |
50-day SMA: | 8.46 | Buy |
200-day SMA: | 8.72 | Sell |
8-day EMA: | 3.4 | Buy |
20-day EMA: | 1.56 | Buy |
50-day EMA: | 0.66 | Buy |
200-day EMA: | 0.17 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.73 | Sell |
20-day SMA: | 8.53 | Sell |
50-day SMA: | 7.48 | Buy |
200-day SMA: | 15.22 | Sell |
8-day EMA: | 8.54 | Sell |
20-day EMA: | 8.42 | Sell |
50-day EMA: | 8.07 | Sell |
200-day EMA: | 12.39 | Sell |
Purpose Global Flexible Crdt ETF NCH CAD Earnings Growth & FLX.B.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Purpose Global Flexible Crdt ETF NCH CAD Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |